Demographics and baseline characteristics
| Total patients enrolled (N = 25) | ||
|---|---|---|
| Variable | Patients, n | % |
| Age, y | ||
| Median | 65 | |
| Range | 46–80 | |
| Sex | ||
| Male | 15 | 60 |
| Female | 10 | 40 |
| ECOG performance status | ||
| 0 | 16 | 64 |
| 1 | 9 | 36 |
| Race | ||
| Caucasian | 24 | 96 |
| African American | 1 | 4 |
| Histology | ||
| Adenocarcinoma | 24 | 96 |
| Acinar | 1 | 4 |
| Location of biopsy | ||
| Liver metastasis | 17 | 68 |
| Primary pancreatic mass | 4 | 16 |
| Omental metastasis | 2 | 8 |
| Other (perihepatic mass, neck lymph node) | 2 | 8 |
| Serum CA 19-9 | ||
| Median, U/mL | 3211 | |
| Range, U/mL | 4–429,939 | |
| >150 U/mL | 18 | 72 |
| Biopsy | ||
| Baseline | 25 | 100 |
| At 3 wks | 23 | 92 |